Hannes Snellman Counsel to Recipharm in the Divestment of its GLP Bioanalysis Business to the Center for Translational Research AB (CTR) Group

4 November 2019

Hannes Snellman acted as counsel to Recipharm, a contract development and manufacturing organisation, in the divestment of its GLP bioanalysis business to the Center for Translational Research AB (CTR) Group.

Our core team included Claes Kjellberg and Jonas Sjöberg.

Follow us on Social Media

General Terms and Conditions
Scam & Fraud Notice
Privacy Notice
Cookie Policy

Hannes Snellman's website is intended for
information purposes only. It should not be
relied upon as legal advice nor should it be
used as a basis for any action or decision.